From analyst to partner, seven Goldman employees shared a look at how the bank's internal ChatGPT-like tool is making their ...

With a market cap of $717 billion, Eli Lilly (LLY) is one of the world’s largest pharmaceutical companies. Lilly is well-known for its innovative drug pipeline and longstanding presence in the global ...

New comanagers Kevin Martens and Jenny Chang leverage Goldman Sachs’ 15-member fundamental equity team to build the portfolio here. The analysts look for businesses with durable growth ...

Goldman Sachs' first-quarter results mostly topped analysts' estimates on Monday, with revenue and profits each rising from ...

Goldman Sachs analysts downgraded their forecast for the dollar, saying they expect the weakness seen in the first quarter to deepen in the months ahead. Here are the reasons they cited ...

Analyst’s Views Ahead of Goldman Sachs’ Q1 Earnings Ahead of Goldman Sachs’ Q1earnings, Morgan Stanley analyst Betsy Graseck downgraded her rating to Neutral from Buy and reduced the price ...

Goldman Sachs Group Inc.’s stock was up 2% Monday after the investment bank topped Wall Street analysts’ estimates for net income and revenue, but the bank warned that its corporate clients ...

The recent initiatives by Goldman Sachs, particularly the sizable US$40 billion share buyback program, aim to reinforce ... efficiencies. However, analysts have varied opinions on earnings ...

Goldman Sachs analyst John Mackay reiterated a Buy rating ... Also Read: Rocket Lab Joins US Space Force’s $5.6 Billion Launch Program; Stock Soars Kinder Morgan anticipates the first-quarter ...

Goldman Sachs joins rivals JPMorgan Chase and Morgan Stanley in posting better-than-expected equities trading revenue.

JMP Securities analyst Devin Ryan maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of ...